Your browser doesn't support javascript.
loading
Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF).
Chojecki, Aleksander L; DiSogra, Kristyn Y; Arnall, Justin; Cowgill, Nicole; Soni, Amy; Packman, Charles H; Sanikommu, Srinivasa Reddy; Shah, Nilay A; Ragon, Brittany K; Knight, Thomas G; Ai, Jing; Avalos, Belinda R; Copelan, Edward A; Grunwald, Michael R.
Afiliación
  • Chojecki AL; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • DiSogra KY; Atrium Health Specialty Pharmacy Service, Atrium Health, Charlotte, NC, USA.
  • Arnall J; Atrium Health Specialty Pharmacy Service, Atrium Health, Charlotte, NC, USA.
  • Cowgill N; Atrium Health Specialty Pharmacy Service, Atrium Health, Charlotte, NC, USA.
  • Soni A; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Packman CH; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Sanikommu SR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Shah NA; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Ragon BK; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Knight TG; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Ai J; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Avalos BR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Copelan EA; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Leuk Lymphoma ; 63(6): 1515-1517, 2022 06.
Article en En | MEDLINE | ID: mdl-35105270
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacia / Médicos / Mielofibrosis Primaria Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacia / Médicos / Mielofibrosis Primaria Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos